Midgard Science
I

Iasobio

Nanjing, China iasobio.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

IASO Bio develops cell therapies and biologics for hematologic malignancies and autoimmune diseases. It operates in Nanjing, Shanghai, and Pleasanton, with global R&D, clinical, and manufacturing activities spanning discovery through commercialization.

Services

  • Fully Human Antibody Discovery Platform

    Uses a fully human antibody library of over 240 billion antibodies, plus synthetic and single-domain libraries, to support discovery of antibody candidates and next-generation therapies.

  • High-throughput CAR-T Cell Therapy Screening and Optimization Platform

    Uses single-cell analysis and next-generation sequencing to screen and optimize CAR-T lead candidates based on phenotypic and functional metrics.

  • In Vivo CAR-T Platform

    Develops in vivo CAR-T products using viral vector engineering, T cell-specific promoters, and proprietary envelope modifications to improve selective T cell transduction and safety.

  • Advanced Manufacturing and CMC Platform

    Provides end-to-end manufacturing and quality systems to support development and commercial-scale production of cell and gene therapy products.

  • Plasmid Manufacturing

    Produces research, GMP-grade, and injectable-grade plasmids using fermentation, purification, in-process analytics, sterilization, and Class A filling.

  • Lentiviral Vector Manufacturing

    Produces lentiviral vectors in a closed, automated, scalable system with batch release testing for identity, potency, sterility, residual DNA, and host-cell protein.

  • Cell Process Development and Manufacturing

    Develops cell products for GMP-compliant manufacturing and supports GMP grade plasmids, viral vectors, and cells.

  • Clinical Development and Clinical Translational Research Platform

    Operates a joint laboratory with a top-tier Chinese hospital to integrate research and clinical development.

1 more services
  • Cell product process development and GMP manufacturing
What to send
  • Single intravenous infusion of IASO208
  • Patients are not required to undergo conventional apheresis or lymphodepleting conditioning

Capabilities

Assays and studies
  • Cell therapy
  • In vivo
  • Antibodies
  • Lentivirus
  • NGS
  • Flow cytometry
12 more
  • Process development
  • Single-cell analysis
  • Next-generation sequencing
  • Molecular detection
  • Cell function assays
  • Identity testing
  • Potency testing
  • Sterility testing
  • Residual DNA testing
  • Host-cell protein assays
  • Cell function testing
  • Host-cell protein testing
Scale and capacity
  • Over 240 billion antibodies
  • Nanjing Facility: approximately 7,866 square meters GFA
  • Shanghai Facility: 32,306 square meters GFA
  • Four global R&D and manufacturing sites
  • Fully integrated platforms spanning the entire product lifecycle
  • Over 240 billion antibodies in the fully human antibody library
3 more
  • Ten products and product candidates
  • Nanjing facility: approximately 7,866 square meters
  • Shanghai facility: 32,306 square meters
Therapeutic areas
  • Hematological malignancies
  • Autoimmune diseases
  • Multiple myeloma
  • Relapsed/refractory B-cell non-Hodgkin lymphoma
  • B-cell malignancies
  • Myasthenia gravis
4 more
  • Multiple sclerosis
  • Systemic lupus erythematosus
  • Lupus nephritis
  • B-cell non-Hodgkin lymphoma

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • mRNA
  • Viral vector
  • Cell therapy
  • Gene editing
  • Plasmid DNA

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: cell product process development

Industries served

  • Advanced therapy medicinal products
  • Cell therapy
  • Gene therapy

Company

Type
CRDMO
Founded
2017

Locations

Address
1 Xinjinhu Road, Jiangbei New District, Nanjing, Jiangsu Province 210018
Sites
  • Shanghai, China
  • Pleasanton, United States
  • Pleasanton, CA, United States
Serves
China, United States, Singapore, Saudi Arabia, United Arab Emirates, Hong Kong, Japan, Australia, Korea

Contacts

Similar labs